Selective COX-2 inhibitors after bariatric surgery: Celecoxib, etoricoxib and etodolac post-bariatric solubility/dissolution and pharmacokinetics
Daniel Porat, Oleg Dukhno, Mazal Partook-Maccabi, Ella Vainer, Sandra Cvijić, Arik Dahan
Topics & Concepts
EtoricoxibEtodolacCelecoxibPharmacokineticsCmaxPharmacologyMedicineSolubilityChemistryOrganic chemistryInflammatory mediators and NSAID effectsChemical Thermodynamics and Molecular StructureNeuropeptides and Animal Physiology